These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8356929)

  • 41. The herpesvirus proteases as targets for antiviral chemotherapy.
    Waxman L; Darke PL
    Antivir Chem Chemother; 2000 Jan; 11(1):1-22. PubMed ID: 10693650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in the development of novel aggrecanase inhibitors.
    Gilbert AM; Bikker JA; O'Neil SV
    Expert Opin Ther Pat; 2011 Jan; 21(1):1-12. PubMed ID: 21110709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Irreversible inhibitors of serine, cysteine, and threonine proteases.
    Powers JC; Asgian JL; Ekici OD; James KE
    Chem Rev; 2002 Dec; 102(12):4639-750. PubMed ID: 12475205
    [No Abstract]   [Full Text] [Related]  

  • 44. [Functional alteration of proteases and mechanisms of inhibitory action of protease inhibitors].
    Kojima S; Miura K
    Tanpakushitsu Kakusan Koso; 1994 May; 39(7):1111-20. PubMed ID: 8016340
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and Application of Activity-Based Probes for Proteases.
    Van Kersavond T; Nguyen MTN; Verhelst SHL
    Methods Mol Biol; 2017; 1574():255-266. PubMed ID: 28315257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A genomic analysis of rat proteases and protease inhibitors.
    Puente XS; López-Otín C
    Genome Res; 2004 Apr; 14(4):609-22. PubMed ID: 15060002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism and Inhibition of Rhomboid Proteases.
    Strisovsky K
    Methods Enzymol; 2017; 584():279-293. PubMed ID: 28065267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of protease and protease inhibitors in cancer pathogenesis and treatment.
    Eatemadi A; Aiyelabegan HT; Negahdari B; Mazlomi MA; Daraee H; Daraee N; Eatemadi R; Sadroddiny E
    Biomed Pharmacother; 2017 Feb; 86():221-231. PubMed ID: 28006747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular evolution of kringles and minikringles found in serine proteases and their inhibitors].
    Takahashi K; Gojobori T
    Tanpakushitsu Kakusan Koso; 1987 Sep; 32(10):1250-69. PubMed ID: 2829278
    [No Abstract]   [Full Text] [Related]  

  • 50. Engineering of proteases and protease inhibition.
    Storer AC
    Curr Opin Biotechnol; 1991 Aug; 2(4):606-13. PubMed ID: 1367681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update 1 of: Proteases universally recognize beta strands in their active sites.
    Madala PK; Tyndall JD; Nall T; Fairlie DP
    Chem Rev; 2010 Jun; 110(6):PR1-31. PubMed ID: 20377171
    [No Abstract]   [Full Text] [Related]  

  • 52. Vialinin A is a ubiquitin-specific peptidase inhibitor.
    Okada K; Ye YQ; Taniguchi K; Yoshida A; Akiyama T; Yoshioka Y; Onose J; Koshino H; Takahashi S; Yajima A; Abe N; Yajima S
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4328-31. PubMed ID: 23791076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure- and fragment-based approaches to protease inhibition.
    Johnson SL; Pellecchia M
    Curr Top Med Chem; 2006; 6(4):317-29. PubMed ID: 16611145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regioselective modification of Lysine's amino groups by proteases.
    Kitaguchi H; Ono M; Itoh I; Klibanov AM
    Agric Biol Chem; 1991 Dec; 55(12):3067-73. PubMed ID: 1368767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new method for filtering of reactive "warheads" of transition-state analog protease inhibitors.
    Traube T; Shokhen M; Albeck A
    Eur J Med Chem; 2014 Apr; 77():134-8. PubMed ID: 24631732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Common feature of the four types of protease mechanism.
    Polgár L
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():327-31. PubMed ID: 2205242
    [No Abstract]   [Full Text] [Related]  

  • 57. Combinatorial strategies for targeting protein families: application to the proteases.
    Maly DJ; Huang L; Ellman JA
    Chembiochem; 2002 Jan; 3(1):16-37. PubMed ID: 17590950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-based inhibitor design by using protein models for the development of antiparasitic agents.
    Ring CS; Sun E; McKerrow JH; Lee GK; Rosenthal PJ; Kuntz ID; Cohen FE
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3583-7. PubMed ID: 8475107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptidyl succinimidyl peptides as taspase 1 inhibitors.
    van den Boom J; Mamić M; Baccelliere D; Zweerink S; Kaschani F; Knauer S; Bayer P; Kaiser M
    Chembiochem; 2014 Oct; 15(15):2233-7. PubMed ID: 25146997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-trefoil inhibitors--from the work of Kunitz onward.
    Renko M; Sabotič J; Turk D
    Biol Chem; 2012 Oct; 393(10):1043-54. PubMed ID: 23089534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.